Burden of anal squamous cell carcinoma, squamous intraepithelial lesions and HPV16 infection in solid organ transplant recipients: A systematic review and meta-analysis.
cancer/malignancy/neoplasia
clinical research/practice
complication: infectious
complication: malignant
immunosuppression/immune modulation
infection and infectious agents - viral
infectious disease
organ transplantation in general
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
18
11
2019
revised:
30
03
2020
accepted:
10
04
2020
pubmed:
29
4
2020
medline:
22
6
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
The number of solid organ transplant recipients (SOTR), and their life expectancy, is increasing, with higher risk for long-term complications from immunosuppression. We carried out a systematic review describing the burden of anal squamous cell carcinoma (SCC), and its surrogates, in SOTR. We conducted mixed effect model-based meta-analyses evaluating incidence of anal SCC (standardized incidence ratio [SIR] vs general population, and absolute incidence rate [IR]), prevalence of anal squamous abnormalities, and human papillomavirus (HPV) 16. Generalized I
Identifiants
pubmed: 32343489
doi: 10.1111/ajt.15942
pii: S1600-6135(22)21632-3
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3520-3528Informations de copyright
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
De Vuyst H, Clifford GM, Nascimento MC, et al. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer. 2009;124:1626-1636.
Lin C, Franceschi S, Clifford GM. Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis. Lancet Infect Dis. 2018;18:198-206.
Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13:487-500.
Saleem AM, Paulus JK, Shapter AP, et al. Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm. Obstet Gynecol. 2011;117:643-649.
Jiménez W, Paszat L, Kupets R, et al. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario. Gynecol Oncol. 2009;114:395-398.
Madeleine MM, Finch JL, Lynch CF, et al. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013;13:3202-3209.
Islami F, Ferlay J, Lortet-Tieulent J, et al. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46:924-938.
Smittenaar CR, Petersen KA, Stewart K, et al. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115:1147-1155.
Soeberg MJ, Rogers K, Currow DC, et al. Trends in incidence and survival for anal cancer in New South Wales, Australia, 1972-2009. Cancer Epidemiol. 2015;39:842-847.
National Health Service Organ Donation and Transplantation Activity Report 2017/18. https://nhsbtdbe.blob.core.windows.net/umbraco-assets/1848/transplant-activity-report-2017-2018.pdf. Accessed July 13, 2019.
Dantal J, Soulillou JP. Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med. 2005;352:1371-1373.
Ogunbiyi OA, Scholefield JH, Raftery AT, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg. 1994;81:365-367.
Collett D, Mumford L, Banner NR, et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit. Am J Transplant. 2010;10:1889-1896.
Chin-Hong PV, Reid GE; AST Infectious Diseases Community of Practice. Human papillomavirus infection in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;e13590.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
Rosales B, Langton-Lockton J, Roberts J, et al. Prevalence of anal cytological abnormalities and human papilloma virus: a cohort study in kidney transplant recipients. Transplantation. 2018;102:S321.
Solomon D, Davey D, Kurman R, et al. Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114-2119.
Darragh TM, Colgan TJ, Cox JT,. et al.; Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012;16:205-242 Erratum in J Low Genit Tract Dis. 2013; 17:368.
Simmonds MC, Higgins JP. A general framework for the use of logistic regression models in meta-analysis. Stat Methods Med Res. 2016;25:2858-2877.
Cai T, Parast L, Ryan L. Meta-analysis for rare events. Stat Med. 2010;29:2078-2089.
Krynitz B, Edgren G, Lindelöf B, et al. Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008-a Swedish population-based study. Int J Cancer. 2013;132:1429-1438.
Sunesen KG, Nørgaard M, Thorlacius-Ussing O, et al. Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005. Int J Cancer. 2010;127:675-684.
Vajdic CM, McDonald SP, McCredie MRE, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296:2823-2831.
Serraino D, Piselli P, Busnach G, et al.; Immunosuppression and Cancer Study Group. Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer. 2007;43:2117-2123.
Patel HS, Silver AR, Levine T, et al. Human papillomavirus infection and anal dysplasia in renal transplant recipients. Br J Surg. 2010;97:1716-1721.
Grąt M, Grąt K, Hołówko W, et al. Initial prevalence of anal human papilloma virus infection in liver transplant recipients. Transpl Int. 2014;27:816-823.
Eleutério J, Cavalcante LR, Gonçalves AKS, et al. Prevalence of high-risk HPV and atypia in liquid-based cytology of cervical and intra-anal specimens from kidney-transplanted women. Diagn Cytopathol. 2019;47:783-787.
Ogilvie JW, Park IU, Downs LS, et al. Anal dysplasia in kidney transplant recipients. J Am Coll Surg. 2008;207:914-921.
Khan A, Obaid T, Cetrulo L, et al. Anal dysplasia among solid organ transplant recipients; a cross sectional study. J Coloproctol. 2019;39:56-61.
Albuquerque A, Pessegueiro Miranda H, Lopes J, et al. Liver transplant recipients have a higher prevalence of anal squamous intraepithelial lesions. Br J Cancer. 2017;117:1761-1767.
Tramujas da Costa e Silva I, de Lima Ferreira LC, Santos Gimenez F, et al. HRA anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol. 2008;15:1470-1475.
Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
Howlader N, Noone AM, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2016. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2016/ (Accessed July 13, 2019).
Marra E, Lin C, Clifford GM. Type-specific anal human papillomavirus prevalence among men, according to sexual preference and HIV status: a systematic literature review and meta-analysis. J Infect Dis. 2019;219:590-598.
Hillman RJ, Cuming T, Darragh T, et al. 2016 IANS international guidelines for practice standards in the detection of anal cancer precursors. J Low Genit Tract Dis. 2016;20:283-291.
Camus M, Lesage A-C, Fléjou J-F, et al. Which lesions should be biopsied during high-resolution anoscopy? Prospective descriptive study of simple morphological criteria. J Low Genit Tract Dis. 2015;19:156-160.
Esser S, Kreuter A, Oette M, et al. German-Austrian guidelines on anal dysplasia and anal cancer in HIV-positive individuals: prevention, diagnosis, and treatment. J Dtsch Dermatol Ges. 2015;13:1302-1319.
Albuquerque A, Cappello C, Cuming T, et al. Anal high-grade squamous intraepithelial lesions in pharmacologically immunocompromised patients followed in a referral Center. Dis Colon Rectum. 2018;61:1267-1272.
Richel O, Prins JM, de Vries HJ. Screening for anal cancer precursors: what is the learning curve for high-resolution anoscopy? AIDS. 2014;28:1376-1377.